Board Meetings for AJANTPHARM

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
AJANTPHARMAjanta Pharma Limited09 Aug 2017ResultsTo consider and approve inter-alia, Unaudited consolidated and standalone Financial Results of the Company for the first quarter ended June 30, 2017.
AJANTPHARMAjanta Pharma Limited03 May 2017Resultsinter-alia to: (1). Consider and approve the audited Financial Results of the Company for the quarter and year ended March 31, 2017 and (2). Consider and approve Financial Statements for the year ended March 31, 2017.
AJANTPHARMAjanta Pharma Limited18 Mar 2017Dividendto consider and approve inter-alia payment of second interim dividend for financial year 2016-17.
AJANTPHARMAjanta Pharma Limited24 Jan 2017ResultsTo consider inter alia approving and taking on record Unaudited (Consolidated & Standalone) Financial Results of the Company for the third quarter ended December 31, 2016.
AJANTPHARMAjanta Pharma Limited26 Oct 2016Results/DividendTo consider inter alia : 1. Approving and taking on record Unaudited (Consolidated & Standalone) Financial Results of the Company for the second quarter and half year ended September 30, 2016. 2. Declaration of interim dividend for financial year 2016-17.
AJANTPHARMAjanta Pharma Limited26 Jul 2016ResultsTo consider and approve inter alia, Unaudited Financial Results of the Company for the first quarter ended June 30, 2016.
AJANTPHARMAjanta Pharma Limited29 Apr 2016Resultsinter-alia to: ( 1). Consider and approve the audited Financial Results of the Company for the quarter and year ended March 31, 2016 and ( 2). Consider and approve Financial Statements for the year ended March 31, 2016.
AJANTPHARMAjanta Pharma Limited09 Mar 2016DividendTo consider and approve inter alia declaration of interim dividend for financial year 2015-16.
AJANTPHARMAjanta Pharma Limited01 Feb 2016ResultsTo consider and approve inter alia, Unaudited Financial Results of the Company for the third quarter and nine months ended December 31, 2015.
AJANTPHARMAjanta Pharma Limited30 Oct 2015Resultsto consider and approve, inter alia Unaudited Financial Results for the second quarter and half year September 30, 2015.
AJANTPHARMAjanta Pharma Limited13 Aug 2015Resultsto consider and approve, inter alia Unaudited Financial Results for the first quarter ended June 30, 2015.
AJANTPHARMAjanta Pharma Limited08 May 2015Results/Dividendto inter alia: 1. Consider and approve the audited Financial Results of the Company for the quarter and year ended March 31, 2015; 2. Consider and approve Financial Statements for the year ended March 31, 2015 3. Recommend dividend, if any, on equity shares of the Company for the financial year 2014-15.
-
AJANTPHARMAjanta Pharma Limited28 Jan 2015ResultsTo consider and approve, inter alia, the Unaudited Financial Results for the third quarter ended December 31, 2014.
AJANTPHARMAjanta Pharma Limited30 Oct 2014ResultsTo consider and approve, inter alia, the Unaudited Financial Results for the second quarter and half year ended 30th September, 2014.
-
AJANTPHARMAjanta Pharma Limited05 Aug 2014ResultsTo consider and approve, inter alia, the Unaudited Financial Results for the first quarter ended June 30, 2014.
-
Showing page 5 of 8 (113 total items)